Newstral
Article
kansascity.com on 2024-04-18 14:30
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company’s In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care
Related news
- MNapo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in Support of Company’s Expanding Focus on Cancer Supportive Caremiamiherald.com
- Incyte signs $77.5M collaboration and licensing deal with Chinese biopharmaceutical companybizjournals.com
- Compulsory Licensing of Biopharmaceutical Inventionsjdsupra.com
- PTAB Update -- Biopharmaceutical Editionjdsupra.com
- SSupportive Celebrationsouthsidemessenger.com
- Chancery Upholds Caremark Claim Based on Alleged Failure to Adequately Monitor Biopharmaceutical Company’s Clinical Trialsjdsupra.com
- Millendo Therapeutics acquires French biopharmaceutical companycrainsdetroit.com
- Iran opens biopharmaceutical factory in Turkeytehrantimes.com
- HSUPPORTIVEhoughtonlakeresorter.com
- Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Carekansascity.com
- LU.S Binding Machine Market Intelligence, Prescriptive Research, Execute Growth Opportunitiesliverpoolstudentmedia.com
- A[OPINION] Voters backed vaccines and biopharmaceutical innovation. Leaders must deliverasianjournal.com
- DNothin’ But a Gi Thingdowneast.com
- Deputies Execute Popular Rancherinfowars.com
- Biopharmaceutical company to build $4 million facility at Navy Yardbizjournals.com
- Regeneron named best biopharmaceutical employer by Science magazinewestfaironline.com
- Biopharmaceutical startup developing a treatment for nerve-agent attacksthenewstribune.com
- Merck debuts new genetic stability process to accelerate biopharmaceutical testingthedailyrecord.com
- Seattle biopharmaceutical startup developing a treatment for nerve-agent attacksSeattle Times